Table 5.
Coagulation abnormalities/clinical prognostic factors and VTE
| Prognostic factors | VTE | non-VTE | P value | ||
|---|---|---|---|---|---|
| No. | % | No. | % | ||
| Temperaturemax (°C) | 0.780 | ||||
| ≥39 | 12 | 46.15 | 4 | 15.38 | |
| <39 | 7 | 26.92 | 3 | 11.54 | |
| Duration of Low BP (h) | 0.171 | ||||
| 0 | 6 | 23.08 | 5 | 19.23 | |
| <72 | 2 | 7.69 | 0 | 0.00 | |
| ≥72 | 11 | 42.31 | 2 | 7.69 | |
| Blood transfusion (ml) | 0.184 | ||||
| 0 | 6 | 23.08 | 5 | 19.23 | |
| ≤800 | 8 | 30.77 | 1 | 3.85 | |
| >800 | 5 | 19.23 | 1 | 3.85 | |
| Lymphocyte | 0.952 | ||||
| ≥1.0 × 109/L | 3 | 11.54 | 1 | 3.85 | |
| <1.0 × 109/L | 16 | 61.54 | 6 | 23.08 | |
| Platelet count | 0.143 | ||||
| ≥150 × 109/L | 14 | 53.85 | 3 | 11.54 | |
| <150 × 109/L | 5 | 19.23 | 4 | 15.38 | |
| SIC score | 0.258 | ||||
| <4 | 17 | 65.38 | 5 | 19.23 | |
| ≥4 | 2 | 7.69 | 2 | 7.69 | |
| DIC score | 0.269 | ||||
| <5 | 12 | 46.15 | 6 | 23.08 | |
| ≥5 | 7 | 26.92 | 1 | 3.85 | |
| Overt DIC | 0.124 | ||||
| Yes | 9 | 34.62 | 1 | 3.85 | |
| No | 10 | 38.46 | 6 | 23.08 | |
| Prolongation of PT (s) | |||||
| >3 | 0 | 0.00 | 0 | ||
| ≤3 | 19 | 73.08 | 7 | 26.92 | |
| Prolongation of aPTT (s) | 0.536 | ||||
| >10 | 1 | 3.85 | 0 | ||
| ≤10 | 18 | 69.23 | 7 | 26.92 | |
| Fbg (g/L) | 0.423 | ||||
| 1.5–4 | 4 | 15.38 | 2 | 7.69 | |
| >4 | 9 | 34.62 | 10 | 38.46 | |
| <1.5 | 0 | 0.00 | 1 | 3.85 | |
| D-dimer (mg/L) | 0.510 | ||||
| ≤0.5 | 2 | 7.69 | 0 | ||
| >0.5 and ≤2 | 5 | 19.23 | 5 | 19.23 | |
| >2 and <5 | 2 | 7.69 | 3 | 11.54 | |
| >5 | 4 | 15.38 | 5 | 19.23 | |
| Antithrombin (%) | 0.627 | ||||
| ≥80 | 11 | 42.31 | 4 | 15.38 | |
| <80 | 5 | 19.23 | 1 | 3.85 | |
| Serum calcium levels (mmol/L) | |||||
| ≥1.8 | 19 | 73.08 | 7 | 26.92 | |
| <1.8 | 0 | 0.00 | 0 | ||
| VTE prophylaxis | 0.78 | ||||
| Yes | 12 | 46.15 | 4 | 15.38 | |
| No | 7 | 26.92 | 3 | 11.54 | |
BP blood pressure, SIC sepsis-induced coagulopathy, DIC disseminated intravascular coagulation, PT prothrombin time, aPTT activated partial thromboplastin time,Fbg fibrinogen, VTE venous thromboembolism
Blood transfusion: red blood cells, platelet or fresh-frozen plasma